RxSight
RXST
212 hedge funds and large institutions have $1.21B invested in RxSight in 2024 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 85 increasing their positions, 61 reducing their positions, and 42 closing their positions.
1,042% more call options, than puts
Call options by funds: $19.8M | Put options by funds: $1.73M
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
39% more repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 61
2.11% more ownership
Funds ownership: 85.54% → 87.65% (+2.1%)
1% less funds holding
Funds holding: 214 → 212 (-2)
5% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 42
28% less capital invested
Capital invested by funds: $1.68B → $1.21B (-$464M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$35.3M |
| 2 |
Credit Agricole
Montrouge Cedex,
France
|
+$26.7M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$22.2M |
| 4 |
Millennium Management
New York
|
+$19.8M |
| 5 |
DDC
DF Dent & Co
Baltimore,
Maryland
|
+$19.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$51.9M |
| 2 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
-$34M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$26.9M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$23.3M |
| 5 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$18.3M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TWD
251
True Wealth Design
Akron,
Ohio
| – | -$1.73K | -35 | Closed |
|
|
AF
252
Allworth Financial
Folsom,
California
| – | -$1.53K | -31 | Closed |
|
253
Bessemer Group
Woodbridge,
New Jersey
| – | -$1K | -20 | Closed |
|
|
CMBA
254
C.M. Bidwell & Associates
Honolulu,
Hawaii
| – | -$395 | -8 | Closed |
|
RXST Hedge Fund Activity: Q4 2024 in Review
212 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q4 2024, worth a combined $1.21B — down 28% from $1.68B a quarter earlier.
Sellers outnumbered buyers: 42 funds closed out of RXST and 40 opened new positions — a net loss of 2 holders — while 61 trimmed existing stakes and 85 added.
The largest buyer was Citadel Advisors, adding an estimated $35.3M. The largest seller was Lord, Abbett & Co, exiting entirely with an estimated $51.9M sold.
- 212 institutional investors held RxSight (RXST) as of Q4 2024, down from 214 in Q3 2024.
- Funds reported $1.21B of RxSight stock for Q4 2024, down 28% quarter-over-quarter.
- 40 funds opened new RxSight positions in Q4 2024 and 42 closed out, a net change of -2 holders.
- The largest RxSight buyer in Q4 2024 was Citadel Advisors, an estimated $35.3M added.
- The largest RxSight seller in Q4 2024 was Lord, Abbett & Co, an estimated $51.9M sold.
Based on aggregated 13F filings for Q4 2024.